Literature DB >> 6824129

Circulating immune complexes and rheumatoid factor in schistosomiasis and visceral leishmaniasis.

E M Carvalho, B S Andrews, R Martinelli, M Dutra, H Rocha.   

Abstract

Circulating immune complexes, measured by the C1q binding and Raji cell radioimmunoassays, were detected in 16 of 25 (64%) patients with schistosomiasis alone, in all 13 patients (100%) with schistosomiasis infection associated with prolonged bacteremia by salmonella organisms, and in 15 of 18 (83%) patients with visceral leishmaniasis. The C3 levels in the serum of patients with schistosomiasis, with and without prolonged salmonella bacteremia, were significantly lower in those with renal disease. Further, in patients with schistosomiasis alone, the absence of renal involvement was positively associated with C1q binding within the normal range (P = 0.015) and the presence of IgM rheumatoid factor in serum (P = 0.04). In six of eight patients with visceral leishmaniasis treated with a pentavalent antimonial, there was a fall in Raji cell binding, suggesting indirectly that the parasitic antigen may be involved in the pathogenic immune complexes in serum.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824129     DOI: 10.4269/ajtmh.1983.32.61

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  23 in total

1.  Immune complex glomerulonephritis in experimental kala-azar. II: Detection and characterization of parasite antigens and antibodies eluted from kidneys of Leishmania donovani-infected hamsters.

Authors:  A Sartori; M C Roque-Barreira; J Coe; A Campos-Neto
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

2.  Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages.

Authors:  Ziyan Yang; David M Mosser; Xia Zhang
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

3.  Autoantibodies to intermediate filaments in sera of patients with Schistosoma mansoni infection.

Authors:  M W Boehme; P K Kataaha; E J Holborow
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

4.  New challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas.

Authors:  Kathryn M Dupnik; Eliana L Nascimento; Joao F Rodrigues-Neto; Tatjana Keesen; Maria Zélia Fernandes; Iraci Duarte; Selma M B Jeronimo
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

5.  Autoantibody production by patients infected with Leishmania.

Authors:  S Argov; C L Jaffe; M Krupp; H Slor; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

6.  Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis.

Authors:  B Galvão-Castro; J A Sá Ferreira; K F Marzochi; M C Marzochi; S G Coutinho; P H Lambert
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

7.  Nature and incidence of erythrocyte-bound IgG and some aspects of the physiopathogenesis of anaemia in American visceral leishmaniasis.

Authors:  L C Pontes De Carvalho; R Badaró; E M Carvalho; J Lannes-Vieira; L Vinhaes; G Orge; M C Marsochi; B Galvão-Castro
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

8.  Serodiagnosis of imported schistosomiasis by a combination of a commercial indirect hemagglutination test with Schistosoma mansoni adult worm antigens and an enzyme-linked immunosorbent assay with S. mansoni egg antigens.

Authors:  Tom Van Gool; Hans Vetter; Tony Vervoort; Michael J Doenhoff; Jose Wetsteyn; David Overbosch
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Immunoblotting identifies an antigen recognized by anti gp63 in the immune complexes of Indian kala-azar patient sera.

Authors:  T Sanyal; D K Ghosh; D Sarkar
Journal:  Mol Cell Biochem       Date:  1994-01-12       Impact factor: 3.396

10.  Identification of leishmanial antigens in the sera of patients with American visceral leishmaniasis.

Authors:  T G Evans; R D Pearson
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.